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a b s t r a c t
Activity-induced nitric oxide (NO) imbalance and “nitrosative stress” are proposed mechanisms of
disrupted Ca2þ homeostasis in atrophic skeletal muscle. We thus mapped S-nitrosylated (SNO)
functional muscle proteins in healthy male subjects in a long-term bed rest study (BBR2-2 Study)
without and with exercise as countermeasure in order to assess (i) the negative effects of chronic muscle
disuse by nitrosative stress, (ii) to test for possible attenuation by exercise countermeasure in bed rest
and (iii) to identify new NO target proteins. Muscle biopsies from calf soleus and hip vastus lateralis were
harvested at start (Pre) and at end (End) from a bed rest disuse control group (CTR, n¼9) and two bed
rest resistive exercise groups either without (RE, n¼7) or with superimposed vibration stimuli (RVE,
n¼7). At subcellular compartments, strong anti-SNO-Cys immunoﬂuorescence patterns in control
muscle ﬁbers after bed rest returned to baseline following vibration exercise. Total SNO-protein levels,
Nrf-2 gene expression and nucleocytoplasmic shuttling were changed to varying degrees in all groups.
Excess SNO-protein levels of speciﬁc calcium release/uptake proteins (SNO-RyR1, –SERCA1 and –PMCA)
and of contractile myosin heavy chains seen in biopsy samples of chronically disused skeletal muscle
were largely reduced by vibration exercise. We also identiﬁed NOS1 as a novel NO target in human
skeletal muscle controlled by activity driven auto-nitrosylation mechanisms. Our ﬁndings suggest that
aberrant levels of functional SNO-proteins represent signatures of uncontrolled nitrosative stress
management in disused human skeletal muscle that can be offset by exercise as countermeasure.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
S-nitrosylation is a posttranslational and reversible redox-
based modiﬁcation of functional proteins and a major source of
nitric oxide (NO) bioactivity thus regulating cellular dynamics and
plasticity in a wide variety of tissues and cell types [1]. By contrast,
uncontrolled over-production or aberrant levels of free radicals
such as superoxide (O2) or nitric oxide (NO) in cells and tissues
provide the basis for oxidative/nitrosative stress induced by
“reactive oxygen/nitrogen species” (ROS/RNS) that increasingly
play central roles in numerous disease states including various
myopathies [2]. For instance, skeletal muscle atrophy induced by
prolonged disuse may induce oxidative stress mechanisms that
accelerate myoﬁber protein degradation [3] via increased sub-
strate recognition of oxidized proteins by E3 ligases (MuRF1-3)
which in turn, promote their susceptibility to proteolysis [4].
An essential step in nitrosative stress is the covalent modiﬁca-
tion of a reactive cysteine residue (–SH) by nitric oxide (NO),
termed S-nitrosation or S-nitrosylation (–SH groups are converted
into –SNO groups) in a given target protein [1]. The reversible
regulation of SNO-protein functions led to the view that nitrosothiols
most likely act as posttranslational modiﬁcations analogous to
phosphorylation or acetylation of functional target proteins [1].
Nitrosothiols are however exceptionally labile because of their highly
reactive potential for intracellular physiological reducing agents
in vivo, such as ascorbic acid and reduced glutathione (GSH) [5], or
reduced metal ions [6]. SNO-protein modiﬁcations may have a tissue
half-life of a few seconds to a few minutes maximum [5] thus
making them particularly difﬁcult to study biochemically.
Recently, a biochemical assay has been developed to study
SNO-proteins by their labeling with a stable biotin linker
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speciﬁcally bound to S-nitrosylated cysteines [7]. The “biotin-
switch technique” (BST) should therefore provide the basis for
indirect SNO-protein detection and puriﬁcation of muscular pro-
teins as putative SNO targets via endogenous nitric oxide (NO)
produced by NO-synthases (NOSs) known to be moderately
expressed in normal human skeletal muscle [8,9] and, for example,
down- or upregulated in atrophic vs. active muscle following
extended bed rest [10]. Vertebrate skeletal muscle is a major
source of NO signals [8] that are key regulators in skeletal muscle
biology including open/close probability of calcium release chan-
nels [11]. The consequences of long-lasting nitrosative stress
conditions following muscle disuse/inactivity in long-term bed
rest and its attenuation by exercise countermeasure during bed
rest remains an open issue.
Given the eminent role of Ca2þ homeostasis in skeletal muscle
physiology, and the fact that dysregulation of intermediate signal-
ing processes underlying Ca2þ homeostasis are closely linked to
disuse-induced muscle atrophy [12,13], we investigated whether
altered levels of subcellular functional SNO-proteins from sarco-
lemmal and sarcoplasmic reticulum calcium-release and -uptake
proteins of a slow or a fast type human leg muscle (soleus, vastus
lateralis) were detectable in muscle biopsies before and after 60
days of 61 head down tilt (HDT) bed rest, i.e., an experimental
immobilisation model that makes use of lower body unloading
resulting in leg muscle disuse, thus permitting the study of
neuromusculoskeletal system deconditioning in healthy subjects
[14]. The bed rest study protocol consisted of two different
exercise plus one control group [15]. This allowed us to address
the ultimate question whether muscle activity on its own would
be able to signiﬁcantly reduce muscular SNO-protein dysregula-
tion, thus mitigating nitrosative stress as a possible negative
regulator of atrophy in human leg skeletal muscles following
long-term bed rest. Further, we might be able to assess which of
the two different exercise protocols, resistive-only (RE) or resistive
vibration exercise (RVE), might be able to more effectively prevent
maladaptation in disused skeletal muscle.
Prolonged muscle disuse in long-term bed rest signiﬁcantly
increased the levels of functional SNO-muscle proteins involved in
Ca2þhomeostasis of a mixed fast-type vastus lateralis or slow-
type soleus in a muscle-speciﬁc way. We also provide evidence for
auto-S-nitrosylation of NOS1 proteins, a major source of NO in
human skeletal muscle ﬁbers [6], and a new candidate on the list
of functional SNO-proteins. Some of these changes were signiﬁ-
cantly offset by RVE, and to lesser extent, by RE countermeasure in
bed rest.
Materials and methods
Bedrest study protocol and biopsies
The 2nd Berlin BedRest Study (BBR2-2) was conducted in the
years 2007–08 at the Charité Campus Benjamin Franklin in Berlin,
Germany. The detailed protocol of the randomized controlled
BBR2-2 study including description of the two exercise counter-
measure trials (RE, RVE) is published elsewhere [15]. Brieﬂy,
twenty-three healthy male subjects underwent 60 days of head-
down tilt (HDT) bed rest. Subjects were randomized to an inactive
bed rest control group (CTR, mean age 33.177.8 yr; n¼9), a bed
rest high-load resistive exercise group (RE, mean age 31.175.1 yr;
n¼7), and a bed rest group that combined high-load resistive
exercise with whole-body vibration (RVE, mean age 32.2710.4 yr;
n¼7). Exercise (RE or RVE) was performed on the same custom
made Galileo Space trainer (Novotec Medical GmbH, Pforzheim,
Germany) while in HDT position, whereas CTR subjects remained
strictly in the HDT supine position without being trained during
the bed rest campaign.
In all groups, open muscle biopsies from soleus (SOL) and vastus
lateralis (VL) muscles were performed six days before (BDC-6) start
(Pre) and two days before (HDT58) the end (End) of bed rest
[15]. The Charité Universitätsmedizin Berlin Ethics Committee
approved this study in accordance to the World Medical Associa-
tion Code of Ethics, Declaration of Helsinki (1964). Subjects gave
their informed written consent prior to participation in the study
and were aware that they were permitted to withdraw from the
study at any time.
Reagents
For the detection of nitrosylated proteins we used the
S-Nitrosylated Protein Detection Kit Cayman (Cayman Chemical Item
Number 10006518). The high capacity streptavidin agarose resin
(PN20361) from Thermo Scientiﬁc was employed (Thermo Fisher
Scientiﬁc, Rockford, USA). Monoclonal antibodies speciﬁc for the
slow myosin heavy chain (sMyHC) (mouse IgG1, clone NOQ7.5.4D),
the fast myosin heavy chain isoforms (fMyHC) (clone My-32), the
α-tubulin (mouse IgG1, clone DM19), and polyclonal (rabbit) for
SNO-Cys (N5411) from Sigma (St. Louis, MO, USA) were used.
Monoclonal antibody speciﬁc for Dystrophin (mouse IgG1, clone
Dy8/6C5) were from Novocastra Laboratories (Newcastle on Tyne,
UK). Monoclonal antibodies for NOS1 (SC-5302), for TRPC1 (SC-
133076) and for nuclear factor-erythroid-2-related factor 2 (Nrf-2)
(SC-365949; rabbit SC-13032) were from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Monoclonal antibodies for RyR1 were from
Alexis Inc. (mouse IgG1, clone 34C, ALX-804-016-R100). Mono-
clonal antibodies for DHPR1α (Clone 1A, AB2862) and for SERCA1a
(clone VE121G9, ab2819) were from Abcam (Abcam Ltd., UK
Cambridge). Monoclonal antibodies for PMCA1 (LS-C87407) were
from LifeSpan (LifeSpan BioSciences, Inc). Secondary antibodies
Alexa 488-conjugated and/or Alexa 555-conjugated afﬁnity-pur-
iﬁed goat anti-mouse and anti-rabbit were from Invitrogen (Invi-
trogen Corporation, CA, USA); alkaline phosphatase-conjugated
(AP) secondary antibodies (Dakos, Glostrup, Denmark) were
visualized with the one step NBT (P-Nitro Blue Tetrazolium
chloride)/BCIP (5-Bromo-4-Chloro-3-Indolyl Phosphate) alkaline
substrate solution buffer from Pierce (Thermo Fisher Scientiﬁc,
LSR Rockford, IL, USA). Protease inhibitor cocktail and Tris–HCl
were from Boehringer Mannheim (Roche Diagnostics, Mannheim,
Germany). All other chemicals were of analytical and molecular
grade. All primary antibodies were diluted at ﬁnal concentration of
2 mg/ml. Secondary AP-conjugated antibodies were diluted 1:500.
Fluorochrome-conjugated secondary antibodies were diluted 1:2000
ﬁnal concentration.
Biotin switch technique (BST)
Equal amounts of muscle biopsy (10 mg) from each Pre and End
bed rest subject (CTR n¼9; RE n¼7; RVE n¼7) were analysed
according to BST established previously [7]. Brieﬂy, free reactive
thiol groups were ﬁrst blocked by incubation of samples with the
thiol-speciﬁc methylthiolating agent methyl methanethiosulfo-
nate (MMTS) in the presence of sodium dodecyl sulfate (SDS) to
ensure access of MMTS to buried cysteines. After blocking free
thiols, nitrosothiol bonds were selectively reduced by using
ascorbate, which results in the reduction of nitrosothiols to thiols.
Total proteins were then precipitated with cold acetone in order to
remove free or unreacted MMTS. In the third and ﬁnal step, the
newly formed thiols were reacted with N-[6-(biotinamido)hexyl]-
3′-(2′-pyridyldithio)-propionamide (biotin-HPDP), a sulfhydryl-
speciﬁc biotinylating reagent thus the previously S-nitrosylated
cysteine residues are ﬁnally biotinylated. Control experiments
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were performed by omitting the biotin-HPDP. Analysis of biotiny-
lated muscle proteins was done blinded using coded samples at
least by triple determination each protein.
Dot-blot analysis
Equal amounts (vol. 3 ml) of biotin-labeled proteins from each
group were spotted on a nitrocellulose membrane using a “BioRad
dot-blot vacuum chamber”, and thereafter incubated in a dry box
at 40 1C for 30 min, washed with TBS-T (Tris-Buffered Saline 0.2%
Tweens 20), preincubated with blocking buffer (TBS-T 2% BSA) for
30 min., and processed for biotin detection using the alkaline
phosphatase-conjugated streptavidin visualized by using the alka-
line phosphatase substrate bromochloro-indolylphosphate/nitro-
blue tetra-zolium salt (BCIP/NBT, Pierce). Proteins were semi-
quantiﬁed by densitometry analysis (GS-800 device, Quantity-
One™ software, BioRad Inc., Munich, Germany).
Streptavidin-agarose afﬁnity chromatography
Biotinylated samples were pooled across the Pre-, respectively
End- bed rest subjects of each experimental group to overcome
possible limitations in the amount of SNO-proteins or the low
relative protein expression in biopsy samples. The biotin-labeled
proteins were then separated from the total protein pool by using
streptavidin-afﬁnity chromatography covalently bound to agarose
beads. Puriﬁed biotinylated proteins were then eluted with 10 mM
EDTA pH 8.2 and 95% formamide 10 min at high temperature.
The presence of SNO-proteins was qualitatively and quantitatively
assayed by Western blot analysis followed by densitometry analysis.
Protein extraction
For Western blot analysis, frozen SOL and VL muscle biopsies
were resolved in RIPA buffer (50 mM Tris–HCl ph 7.4, 150 mM
NaCl, 1% NP-40, 0.5% sodium deoxicholate, 0.1% SDS, 2 mM MgCl2
in presence of a protease inhibitor cocktail). A glass Dounce
homogenizer was used with 20 strokes per sample. Tissue extracts
were centrifuged at 14,000g, 15 min at 4 1C. Protein concentration
of the soluble fraction was determined by using a colorimetric
assay kit (Pierce) and stock solutions were made and stored at
80 1C until used.
Western blot analysis
Samples (CTR n¼9; RE n¼7; RVE n¼7) were diluted (to 3 mg/ml
ﬁnal concentration) into an SDS-containing loading buffer, heated
to 95 1C for 5 min before an aliquot (10 μL) of each assay sample
was loaded onto a Tris–glycine polyacrylamide gel (Bio-Rad).
Proteins were resolved by electrophoresis in SDS-containing run-
ning buffer. Proteins were transferred to a nitrocellulose mem-
brane and then blocked overnight at 4 1C with TBS-T (Tris-buffered
saline, pH 7.5, 0.2% Tweens 20) supplemented with 4% non-fat dry
milk. The membrane was probed with the primary antibody in
TBS-T supplemented with 4% non-fat dry milk. Rinsed blots were
incubated for 1 h with anti-rabbit or anti-mouse or anti-goat
alkaline phosphatase-conjugated secondary antibodies diluted
1:500 in TBS–T solution, rinsed again, and ﬁnally detected using
the alkaline phosphatase substrate bromochloro-indolylpho-
sphate/nitroblue tetrazolium salt (BCIP/NBT, Pierce). Protein con-
tent was quantiﬁed by densitometry using the GS-800 device
(Quantity-One™ software, Bio-Rad). α-tubulin was used as a protein
load marker.
SNO-Cys immunohistochemistry and laser confocal analysis
Cryosections (8 mm thickness) from SOL and VL muscles of
“Pre” and “End” bed rest groups (n¼5 each) were double-labeled
with commercial antibodies raised against SNO-Cys and NOS1.
Primary antibodies were visualized using goat anti-rabbit (Alexa
488-conjugated) and anti-mouse (Alexa 555-conjugated) antibo-
dies respectively diluted at a ﬁnal concentration of 2 mg/ml. Our
protocols included subject-matched (End- vs. Pre-bed rest) cryo-
sections in order to balance inter-subject variability and achieve
comparable immunostaining conditions.
Confocal microscopy
Immunoﬂuorescence images were acquired with a Leica DM
RE7 upright microscope equipped with a three-channel confocal
laser system (Leica TCS SP-2, Leica Microsystems, Bensheim,
Germany) using the HCX PL APO CS 40x/1.25 Oil objective. The
relative ﬂuorescence intensity of immunostained subcellular com-
partments from at least twenty (n¼20) myoﬁbers from each
cyosection of each subject was determined according to an
established protocol [10,16]. Brieﬂy, the area pixel intensity of a
selected region of interest (ROI) was measured from the digitized
confocal image scans and expressed as arbitrary units (a.u.), in the
range of 0 to 255 a.u.. Changes of ﬂuorescence intensity referable
to SNO-Cys determined in samples of individual subjects and
groups, were calculated as the percentage change of a.u. of End-
vs. Pre-bed rest (baseline). All digitized images were analyzed
using the Leica confocal software (License number: 156108810,
Version 2.61.1537).
SNO-Cys positive/negative control
Cryosections from human SOL CTR-Pre bed rest were pre-
incubated with 50 mM NaNO2, 0.5 M HCl, at 37 1C for 20 min.
(positive control), or with the blocking reagent HgCl2 solution at
0.2% for 30 min. at 37 1C (negative control, according to the A.G.
Scientiﬁc manufacture protocol), and processed pair-wise for anti-
SNO-Cys immunohistochemistry.
RNA extraction and quantitative real-time polymerase chain
reaction (qPCR)
RNA extraction and quantitative Real-Time Polymerase Chain
Reaction (qPCR)- RNA was isolated from human skeletal muscles
BR biopsies (SOL CTR, RE and RVE n¼5; VL CTR and RE n¼5, RVE
n¼4) using RNeasy ﬁbrous tissue mini kit (QIAGEN) according to
the manufacturer’s instructions as previously reported by Salanova
M. et al. [17]. Brieﬂy, 200 ng of RNA were transcribed in cDNA by
using SuperScripts VILO™ cDNA Synthesis Kit (Invitrogen). Cyclo-
philin A (PPIA), beta-2-microglobulin (B2M) and ribosomal protein
L32 (RPL32) were used as reference genes [17]. The PCR para-
meters were initial denaturation at 95 1C for 30 s followed by 40
cycles of 10 s at 95 1C and 30 s at the corresponding annealing
temperature (55 1C for Nrf-2 and for PPIA, B2M, and RPL32) for the
acquisition of ﬂuorescence signal. All samples were run simulta-
neously with RNA- and RT-negative controls. Both, a melting curve
and normalization were performed as previously reported by
Salanova M. et al. [17].
The speciﬁc primers for Nrf-2 were the same published by
Brocca L. et al. [18]. Speciﬁc primers for PPIA, B2M and RPL32
are reported in Salanova M. et al. [17]. Data are expressed as
means7SEM. Comparisons were made by using t-test, with
Po0.05 being considered statistically signiﬁcant.
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Nuclear factor-erythroid-2-related factor 2 (Nrf-2) myonuclei
translocation
Human skeletal muscle biopsy cryosections (8 mm thickness),
from SOL (n¼7) and VL (n¼7) pre- and end-BR groups, were
double immunolabelled with anti-Dystrophin and anti-Nrf-2 anti-
bodies. In all Nrf-2 immunostaining protocols we used goat anti-
rabbit Alexa-488 for Nrf-2 and goat anti-mouse Alexa-555 for
Dystrophin. Nuclei were counterstained with blue DAPI.
Double immunostained muscle cryosections were then inspected
by epiﬂuorescence microscopy enabling the detection of Nfr2-
accumulation in myonuclei. Particularly, a meandering screening
pattern was used for myonuclei detection in both, SOL and VL
cryosections. Brieﬂy, more than cytosolic Nrf-2 baseline immunoﬂuor-
escence Nrf-2 accumulation was deﬁned as Nrf-2 myonuclei translo-
cation positive, whereas a decrease in nuclear Nrf-2 accumulation
below cytosolic baseline or cytosol-like nuclear was determined as
Nrf-2 myonuclei translocation negative. At least 50 myonuclei were
scored each subject/biopsy.
Statistical analysis
Statistical analyses were performed using SigmaPlot version
9.0 software. Results are given as mean 7SE. Signiﬁcance of
Fig. 1. SNO-protein assay in human skeletal muscle biopsies. A. Dot blots analysis (left panel) biotin-labeled proteins (reﬂecting SNO-proteins) in soleus (SOL) of End vs. Pre
bed rest subjects (1,2,3: triplicate), Control BST was obtained by omitting biotin-HPDP during the protocol; right panel, dot blot densitometry analysis. B. (left panel) Dot blot
analysis of biotin-labeled proteins in vastus lateralis (VL) of End vs. Pre bed rest subjects (1,2,3: triplicate), Control BST was obtained by omitting biotin-HPDP during the
protocol; right panel, dot blot densitometry analysis. A signiﬁcant increase of biotin incorporation is observed in CTR group (n¼9) in both muscles (SOL, Pre 86.5172.9, End
95.6476.5; VL Pre 192.9473.07, End 222.5976.6). In the RE group (n¼7) a signiﬁcant increase was in VL only (Pre 123.0774.7, End 145.675.56) but not in SOL after bed
rest. RVE (n¼7) only signiﬁcantly decreased SNO-protein levels in both SOL (Pre 75.370.75, End 62.2571.7) and VL (Pre 144.5273.8, End 122.3274.1). C. NOS1 WB
analysis of BST streptavidin column eluate vs. normal muscle lysates (Muscle lysate). In both SOL and VL, NOS1 immunoreactive bands with higher relative mobility are
detectable (BST/Eluate) vs. a predicted NOS1 immunoreactive band obtained from total muscle lysates used as positive control.
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differences of data was analyzed with Student’s t-test and by
one-way ANOVA. Differences were considered to be signiﬁcant at
Pr0.05 (n).
Results
Biotinylated proteins reﬂecting SNO-proteins in human skeletal
muscle biopsies following bed rest and exercise countermeasures
A signiﬁcant increase in the amount of biotin-labeled proteins,
reﬂecting the relative SNO-protein levels in muscle biopsies was
clearly documented after bed rest in both SOL and VL muscle
biopsy samples (CTR SOL 18.5%; VL 19%) (Fig. 1A). However, from
the two types of countermeasures only RVE was able to prevent
such changes in both types of muscles (SOL19%; VL17%). In the
RE group, no change in slow-type SOL (3.3%) and a signiﬁcant
increase in mixed-fast-type VL (þ16%) was found, suggesting the
presence of muscle-speciﬁc (fast vs. slow type) SNO-protein levels
(Fig. 1A). Control experiments performed by omitting the biotin-
HPDP during the BST experimental protocol showed no biotin-
labeled proteins in any bed rest samples, suggesting no interfer-
ence of the endogenous biotin in our experiments (Fig. 1A Inset,
line Control BST).
S-nitrosylation of NOS1 (SNO-NOS1) protein in human
skeletal muscle
NOS1 is abundantly expressed in skeletal muscle and respon-
sible for activity-dependent NO-signaling pathways in myoﬁbers.
As revealed by Western blot experiments, NOS1 protein was
present in BST streptavidin column eluate (Fig. 1B) of both
muscles. Note the shift in the relative mobility of the biotin-
labeled NOS1 protein (SNO-NOS1, BST/Eluate) when compared to
native NOS1 protein immunodetected in control (Muscle lysate)
samples (Fig. 1b). As shown in Fig. 2A and B upper panel, NOS1
proteins were expressed in all Pre- and End-bed rest muscle
biopsy lysates. Comparable levels of SNO-NOS1 proteins were
present in both SOL and VL muscles biopsies of BST streptavidin
column eluate of both Pre and End-bed rest subjects (Fig. 2A and B
middle panel). A densitometry analysis conﬁrmed a decrease of
both NOS1 and SNO-NOS1 in the CTR group and an increase in the
RE and RVE groups in both muscles after bed rest (Fig. 2A and B,
lower panel).
Anti-nitrosocystein (SNO-Cys) immunohistochemistry in human SOL
and VL muscles
SNO-Cys immunohistochemistry performed on cross-cut cryo-
sections revealed a general pattern of myoﬁber SNO-proteins that
we considered as steady-state (baseline) before bed rest was
commenced. As shown in Fig. 3A (Pre column, green channel), a
moderate SNO-Cys immunoreactivity was present in Pre-bed rest
muscle biopsies of CTR subjects at the three main subcellular
compartments (arrows): subsarcolemmal, cytosolic, and sarcoplas-
mic reticulum-myoﬁbrillar.
Confocal analysis of sarcolemma membrane areas conﬁrmed an
overlapping pattern of anti-SNO-Cys with anti-NOS1 immuno-
signals (Fig. 3A, Pre, green and red channels) that was considered
as baseline co-immunolocalization of SNO-Cys and NOS1 at the
sarcolemma region.
After bed rest signiﬁcant increases in subsarcolemmal and
intracellular SNO-Cys immunoﬂuorescence were clearly observa-
ble in the CTR group (Fig. 3A, End). This could be additionally
conﬁrmed by confocal S-nitrosocystein ﬂuorescence intensity
analysis (Fig. 3A, lower panel), thus suggesting that prolonged
muscle disuse in bed rest induced an augmented relative immu-
noexpression pattern of muscular SNO-proteins at various sub-
cellular myoﬁber compartments (Fig. 3A) which was prevented by
RE and RVE countermeasure protocols (data not shown). Positive
control experiments using sodium nitrite showed a signiﬁcant
Fig. 2. BST-related SNO-NOS1 protein assay of human SOL and VL muscle biopsies
before and after bed rest. A. Upper panel, NOS1 WB analysis of SOL lysates
normalized to alpha tubulin. A. Middle panel, NOS1 WB analysis of BST-streptavidin
column eluate in SOL lysates. NOS1 protein immunoreactive bands reﬂecting
biotin-labeled NOS1 proteins were present in all eluate samples showing the
presence of S-nitrosylated NOS1 proteins in human SOL. A. Lower panel, graph
representing percent changes of NOS1 (white columns, CTR (n¼9), 32%, pr0.01;
RE (n¼7), 12.7%, pr0.05; RVE (n¼7), 31.2%, pr0.01) and of SNO-NOS1 (black
columns, CTR (n¼9), 40%, pr0.01; RE (n¼7), 42.5%, pr0.01; RVE (n¼7), 60.6%,
pr0.01) proteins in SOL of End vs. Pre bed rest biopsies (Pre values are set up as
zero baselines). B. Upper panel, NOS1 WB analysis of VL lysates normalized to alpha
tubulin. B. Middle panel, NOS1 WB analysis of BST-streptavidin column eluate in VL
lysates. NOS1 protein immunoreactive bands reﬂecting biotin-labeled NOS1 pro-
teins were present in all eluate samples showing the presence of S-nitrosylated
NOS1 proteins in human VL. B. Lower panel, graph representing percent changes of
NOS1 (white columns, CTR (n¼9), 9.84%, pr0.05; RE (n¼7), 16.2%, pr0.01; RVE
(n¼7), 9.5%, pr0.05) and of SNO-NOS1 (black columns, CTR (n¼9), 12%,
pr0.05; RE (n¼7), 10.45%, pr0.05; RVE (n¼7), 15.65%, pr0.01) proteins in VL
lysates of End vs. Pre bed rest samples (Pre values are set up as zero baselines).
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increase in anti-SNO-Cys ﬂuorescence intensity within myoﬁber
subcellular compartments (Fig. 3B, Control), conﬁrming speciﬁcity
of anti-SNO-Cys antibodies immunolabelling that was abolished
by pre-incubation of the tissue with mercury chloride a blocking
reagent solution (Fig. 3C, negative control).
Fast- and slow-type SNO-myosin heavy chain (MyHC) proteins
MyHC proteins are abundantly expressed key proteins of the
myoﬁbrillar protein fraction that could well be targets for aberrant
SNO modiﬁcations in disused muscle. A signiﬁcant increase in
biotin-labeled fast-MyHC proteins reﬂecting SNO-fast-MyHC pro-
teins was present in SOL (138%) and VL (300%) of End-bed rest CTR
group, while both RE and RVE countermeasure protocols pre-
vented or even decreased (RE SOL, 99%, VL, 15%; RVE SOL,
16%, VL, 80%) such modiﬁcations in both muscles (Fig. 4A,B,
upper panel). Conversely, a decrease in biotin-labeled slow-MyHC,
was documented in SOL (22%) but not in VL (13%) of End-bed
rest CTR group. In RE, however, a signiﬁcant increase in slow SNO-
MyHC proteins was present in SOL (51%) that was not detectable in
VL (92%). Only RVE was able to prevent or decrease (SOL 99%;
VL 95%) the levels of slow SNO-MyHC proteins in both SOL
and VL muscles following bed rest (Fig. 4).
SNO-RyR1
The ryanodine receptor protein type 1 (RyR1) represents the
major intracellular Ca2þ-release channel responsible for calcium
efﬂux from sarcoplasmic reticulum to the cytosolic compartment.
We found moderate SNO-RyR1 protein levels in all Pre-bed rest
Fig. 3. Confocal S-nitrosocystein (SNO-Cys) immunohistochemistry analysis in human skeletal muscle biopsies. A. Before start of bed rest (Pre) anti-SNO-Cys, anti-NOS1, and
merged images (Merge). Anti-SNO-Cys antibodies immunolabelled the subsarcolemmal compartment (arrows, green ﬂuorescence channel) that almost fully overlapped
with anti-NOS1 antibodies immunostaining, red channel immunoﬂuorescence signals (red and green merged yellow pixel area in 3D co-localization box plot at bottom
panel), the cytosol/sarcoplasmic reticulum (SR)/myoﬁbrillar compartment (asterisks). After bed rest (End), signiﬁcantly increased SNO-Cys immunoﬂuorescence was seen in
SOL. A. Lower panel, graph representing anti-SNO-Cys immunosignal intensity in CTR Pre and End bed rest SOL. Signiﬁcant changes in NOS1 (not shown) and SNO-Cys
proteins were detected by intracellular pixel area intensity analysis (CTR (n¼5) Pre, 36.55, pr0.01; CTR (n¼5) End, 75.55, pr0.01) and sarcolemmal (CTR (n¼5) Pre, 77.78,
pr0.01; CTR (n¼5) End, 143.89, pr0.01). B. Positive control. Cryosection was pre-incubated with NaNO2 (producing nitroso compounds) followed by SNO-Cys
immunostaining. C. Negative control. Cryosection was blocked by pre-incubation with HgCl2 followed by anti-SNO-Cys immunostaining. Bar¼50 mm. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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samples reﬂecting baseline (Fig. 5A). However, in CTR without
exercise (CTR End-bed rest), a signiﬁcant increase in SNO-RyR1
protein levels was present in biopsies of both SOL (18.6%, Fig. 5B)
and VL (17.2%, Fig. 5B). Conversely, both exercise countermeasure
protocols (RE or RVE) counteracted such excess levels of RyR1
post-translational SNO modiﬁcations in both SOL and VL muscle
(Fig. 5B).
It is well known that RyR1 channel activity is modulated by
calcium binding protein calsequestrin (CSQ) 1 and 2. To further
study RyR1 regulatory proteins, the presence of CSQ 1 and 2 was
investigated in the BST streptavidin column eluate. CSQ 1 or 2 were
never detectable in any of the Pre and End BR muscle samples
(data not shown) suggesting that CSQ proteins could be used as a
negative internal control biomarkers (lacking SNO-moieties) in our
human skeletal muscle experiments.
SNO-SERCA
The sarco(endo)plasmic reticulum Ca2þ-dependent ATPase
SERCA1a is responsible for Ca2þ uptake from the cytosol into the
sarcoplasmic reticulum lumen and intracellular calcium store of
fast-type myoﬁbers. Like RyR1, however, moderate SNO-SERCA
levels were found in all Pre bed rest samples (Fig. 6A and B, upper
panel). Following disuse in bed rest, a signiﬁcant increase of SNO-
SERCA1a levels was present in SOL (330%) or VL (220%) of CTR
group (Fig. 6A and B, upper and lower panel). Thus, high amounts
of SNO-SERCA1a protein levels were documented following
extended muscle disuse independently of the muscle type. How-
ever, opposite results were obtained in the RE group (SOL, 180%;
VL, 41%), suggesting that RE highly induced functional SNO-
SERCA protein levels in a typically muscle-speciﬁc pattern. Similar
results were found in the RVE group with the sole difference that
in SOL an increase of the SNO-SERCA1 levels was more attenuated
(75%), while in VL the SNO-SERCA1 levels were largely maintained
or reduced (40%, Fig. 6A and B, lower panel).
SNO-SERCA2a protein levels speciﬁcally expressed in slow-type
myoﬁbers (immunoblots not shown) by densitometry analysis
(Fig. 6A and B, lower panel) were found unchanged after bed rest
muscle disuse in all groups. These results conﬁrm that a moderate
SERCA1 and SERCA2 S-nitrosylation may be principally required
for normal SERCA-ATPase activity in both muscles – independent
Fig. 4. BST detection of SNO-myosin heavy chain (MyHC) proteins in bed rest
muscle biopsies. A. Immunoblotted BST streptavidin column eluate of SOL inves-
tigated for the presence of fast- (upper panel) and slow-type (lower panel) MyHC.
Signiﬁcant decrease in slow-type (22%, pr0.05) and increase in fast-type (138%,
pr0.01) MyHC was present in CTR (n¼9) End bed rest biopsies. In the RE group
(n¼7), an increase of slow-type (51%, pr0.01) and a decrease of fast-type (99%,
pr0.01) MyHC was seen. In the RVE (n¼4) group, both slow-type (99%, pr0.01)
and fast-type (16%, pr0.05) MyHCs levels were equally decreased. B. Slow- and
fast-type MyHC (s/fMyHC) immunoblot analysis of BST streptavidin column eluate
of VL. Signiﬁcant increase of slow-type (13%, pr0.05, lower panel) and fast-type
(300%, pr0.01) MyHCs were present in CTR (n¼9) End bed rest biopsies. In the RE
group (n¼7), a decrease of slow-type (92%, pr0.01) and fast-type (15%,
pr0.05) MyHC was present. In the RVE group (n¼7), both slow- (95%,
pr0.01) and fast-type (80%, pr0.01) MyHC levels were equally decreased.
Fig. 5. BST detection of SNO-RyR1 in human skeletal muscle SOL and VL biopsies.
A. Upper panel, Immunoblot of BST streptavidin column eluate of SOL for RyR1. A.
Lower panel, Immunoblot of BST streptavidin column eluate of VL for RyR1.
Increased RyR1 immunoreactive band was detected in CTR End-only samples.
B. Percent changes biotin-labeled RyR1 proteins from Pre and End bed rest biopsies.
Bed rest without exercise promoted S-nitrosylation of RyR1 in disused SOL (CTR
n¼9, 18.6%, pr0.01) and VL (CTR n¼9, 17.2%, pr0.01) as counteracted by both
exercise countermeasures. (* signiﬁcance).
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of muscle activity, whereas only SERCA1 is speciﬁcally affected by
nitrosative stress following extended muscle disuse.
SNO-DHPR1α
The voltage-gated ion channel dihydropiridine receptor 1 alpha
(DHPR1α) is expressed at the T-tubule sarcolemma infolding of
skeletal myoﬁbers and is reported to be functionally linked (by
physical contact) to the intracellular Ca2þ release channel RyR1. In
our experiments, comparable levels of SNO-DHPR1α antigens were
present in all bed rest BST/streptavidin column eluate (Fig. 7A,
upper and middle panel) suggesting that a moderate level of
S-nitrosylated DHPR1α is required for the physiological regulation of
their functional activity. However, densitometry analysis revealed
no signiﬁcant changes in the levels of SNO-DHPR1α proteins were
present in either SOL or VL muscle biopsies following bed rest only
or bed rest with exercise countermeasures (Fig. 7A, lower panel).
SNO-IP3R1
Inositol 1,4,5-trisphosphate receptor 1 (IP3R1), together with
the RyR1, is one of the two well-characterized intracellular calcium
release channels in skeletal muscle. IP3R1 antigens were present in
all Pre and End bed rest of BST/streptavidin column eluate (Fig. 7B,
upper and middle panel). However, by densitometry analysis, no
signiﬁcant changes in SNO-protein levels were present in both SOL
and VL muscle biopsies after the bed rest period (Fig. 7B, lower
panel) suggesting that – similarly to the DHPR1α results –
moderate SNO-IP3R1 protein levels are required for a physiological
regulation of their functional activity.
SNO-TRPC1
The transient receptor potential (TRP) channel is a Ca2þ
channel protein localized at the outer plasma membrane and
responsible for calcium inﬂux from extracellular compartment
into intracellular myoﬁber compartment. TRPC1 antigens were
not found in Pre and End bed rest muscle biopsies of BST/
streptavidin column eluate of both SOL and VL muscle (Fig. 7C).
A predicted TRPC1 immunoreactive band of 92 kDa was present on
total muscle lysates used as positive control. Taken together these
results suggested that no functional regulation mechanisms
through S-nitrosylation mechanisms are present on TRPC1 in
human SOL and VL skeletal muscle.
SNO-PMCA1
The plasma membrane Ca2þ-ATPase type-1 (PMCA1) is respon-
sible for Ca2þ extrusion from the intracellular (cytosol) to the
extracellular myoﬁber compartment. As revealed by anti-PMCA1
immunoblotting experiments, comparable levels of PMCA1 anti-
gens were present in all Pre-bed rest streptavidin-column eluate of
each group and muscle (Fig. 8A, upper and lower panel). These
ﬁndings are consistent with our SERCA1 results, suggesting that
moderate S-nitrosylation of PMCA1 (SNO-PMCA1) might be
required for physiological regulation of Ca2þ-ATPase activity in
normal human skeletal muscle ﬁbers (Fig. 8A). After bed rest,
however, a trend to enhancement of SNO-PMCA1 levels was seen
in SOL biopsies of CTR and RE End bed rest subjects while in VL
biopsies there was a signiﬁcant increase only in End bed rest
biopsies of CTR subjects. Conversely, the RE and RVE counter-
measure protocol signiﬁcantly decreased SNO-PMCA1 in VL
biopsies (Fig. 8B).
Due to the low relative protein expression of PMCA1 in skeletal
muscle when compared to the robust levels of SERCAs, RyR1 and/
or MyHCs, the SNO-PMCA1 protein analysis should be further
investigated to verify our ﬁndings.
Nuclear factor-erythroid 2-related factor 2 (Nrf-2) transcripts in SOL
and VL muscle biopsies of BR subjects
Nrf-2 transcripts were present in biopsies of SOL (left panel)
and VL (right panel) from all pre-bed rest volunteers, although
with slight differences in their relative expression levels (Fig. 9A).
An increase in Nrf-2 transcripts after BR-only was detected in VL
(Pre, 0.53970.065; End, 0.75170.023) whereas in SOL (Pre,
0.42170.018; End, 0.61870.1) a clear trend was found. However,
no signiﬁcant changes in Nrf-2 transcripts were detected in both
muscles of either exercise countermeasure groups (Fig. 9A).
Nrf-2 myonuclei translocation
A detailed morphometric analysis of Nrf-2 cytosol-to-myonuclei
shuttling by triple-immunohistochemistry of biopsy cryosections
Fig. 6. BST detection of sarcoplasmic reticulum SNO-SERCA1/–SERCA2 in human
skeletal muscle SOL and VL biopsies from bed rest groups. A. Upper panel,
Immunoblot of SERCA1 in BST streptavidin column eluate of SOL; lower panel,
percent changes SNO-Cys-SERCA1 and SNO-Cys-SERCA2 of End vs. Pre bed rest SOL
(Pre values are set up as zero baselines). An increase of SNO-SERCA1 in CTR (330%,
pr0.01, n¼9), RE (180%, pr0.01, n¼7), and RVE (75%, pr0.01, n¼7) group was
detected (*). No changes were observed for SNO-SERCA2 proteins. B. Upper panel,
Immunoblot of SERCA1 of streptavidin column eluate of VL; lower panel, percent
changes SNO-Cys-SERCA1 and SNO-Cys-SERCA2 of End vs. Pre bed rest VL (Pre
values are set up as zero baselines). An increase of SERCA1 (220%, pr0.01, n¼9)
was present in CTR End subjects, while a decrease was present in RE (-41%, pr0.01,
n¼7) and RVE (-40%, pr0.01, n¼7) subjects (*). No changes were observed for
SNO-SERCA2 proteins.
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was performed in all groups (Fig. 9B). Quantitative determination
(Fig. 9C) showed that the percentage of Nrf-2 positive myonuclei
was slightly reduced in both SOL (Pre, 10.9370.66%, End,
9.0370.75%) and VL (Pre, 9.8370.71%, End, 8.3370.86%) of CTR
group after bed rest. In the RE group, a trend was seen in both SOL
(Pre, 9.6270.77%, End, 11.2571.19%) and VL (Pre, 8.7770.54%,
Post, 9.3970.54%). In the RVE group, a signiﬁcant increase in Nrf-2
positive myonuclei was present in SOL (Pre, 10.3570.62%, End,
13.5370.89%), but not in VL (Pre, 10.6870.68%, End, 12.367
0.88%). Although the percentage of Nrf-2 positive myonuclei was
not always signiﬁcantly changed in both muscles of all groups, a
clear trend between groups without and with exercise counter-
measures was present. Thus, exercise intervention in bed rest
(RE, RVE) is apparently reﬂected by altered patterns of Nrf-2
nucleocytoplasmic shuttling in either human skeletal muscle,
preferentially in SOL after 60 days of bed rest.
By Western blot analysis a faint Nrf-2 immunoreactive band
was detected in all bed rest biopsies RIPA extracts (Fig. 9D).
However, since part of the protein amount could be retained in
the pellet nuclei, further studies are required to deﬁne the
cytosolic and nuclei fraction ratio. Jurkat whole cell lysates were
used as positive control.
Discussion
We propose here that altered protein S-nitrosylation likely
reﬂects variable nitrosative stress management affecting components
of the excitation–contraction (EC) coupling machinery, and thus
calcium homeostasis in disused human skeletal muscle following
60 days of bed rest.
Protein S-nitrosylation of functional muscle proteins most
likely serve as a key mechanism in the routine control of intra-
cellular calcium homeostasis in active skeletal muscle [18,19]
while aberrant SNO posttranslational modiﬁcations such as in
inactive/disused muscle may account for leaky calcium channels
due to increased nitrosative stress, as previously proposed for
atrophic muscle ﬁbers [2,20,21] or by exposure to redox modifying
agents [22].
Our results support the hypothesis that disuse-induced muscle
atrophy results from disrupted Ca2þ homeostasis, i.e., substantial
increase of cytosolic free Ca2þ concentration as previously pro-
posed [23,24] which in turn may cause activation of several Ca2þ-
dependent proteolysis/signaling pathways [25,26].
Thus, we here speculate that excess levels of SNO-proteins are
likely to promote disuse-induced atrophy via calcium/calpain-
associated proteolysis in human skeletal muscle during bed rest.
Evidence supporting this hypothesis is provided by the increased
biotin labeled (reﬂecting S-nitrosylated) levels of intracellular
Ca2þ-release and Ca2þ-uptake proteins such as the sarcoplasmic
reticulum-associated RyR1 and SERCA1 and, most probably, the
plasma membrane-associated PMCA1, or even the slow and fast
MyHC proteins of the myoﬁbrillar contractile apparatus suggestive
for altered individual components of the E–C coupling machinery.
Accordingly, this would be the ﬁrst study showing elevated
S-nitrosylation levels of speciﬁc E–C coupling regulatory and
contractile proteins that are inversely regulated by human muscle
activity.
The present results are in agreement with previous studies
showing increased protein oxidative stress by muscle protein
S-nitrosylation [16,27] and/or carbonylation [28,29], or even
altered total thiol protein (SH) group concentrations and
Fig. 7. BST detection of sarcolemmal and sarcoplasmatic reticulum functional channel proteins in human skeletal SOL and VL from bed rest subjects. A. Upper and lower
panel, DHPR1α immunoblot of BST streptavidin column eluate of SOL and VL. A moderate presence of DHPR1α proteins was present in all groups (CTR n¼9; RE n¼7; RVE
n¼7). B. Upper and lower panel, IP3R1 immunoblot of BST streptavidin column eluate of SOL and VL. A moderate presence of IP3R1 proteins was present in all groups (Pre). No
changes were present in both samples after bed rest (End) (CTR n¼9; RE n¼7; RVE n¼7). C. Left and right panel, TRPC1 immunoblot of BST streptavidin column eluate of SOL
and VL (CTR n¼9; RE n¼7; RVE n¼7); (Contr.¼positive control of total proteins muscle lysates). No SNO-TRPC1 protein signals were detectable in either group before and
after bed rest.
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antioxidant activity [30] after bed rest, or S-nitrosylation of MyHCs
in rat skeletal muscle [31].
Altered S-nitrosylated proteins detected in the present study
may, at least partially, be due to changes in the relative protein
expression and changes in the intrinsic protein S-nitrosylation
ratio, for example, in response to altered muscle activity [12,32] or
myoﬁber phenotype transition [33]. Nevertheless, the observed
changes in protein S-nitrosylation ratio of MyHCs in the RE /RVE
exercise groups clearly do not reﬂect major changes in the relative
protein expression (Fig. 4A and B). In addition, the relatively
low protein expression of some functional proteins (like PMCA)
in our protein preparations or the reduced protein mobility
because of biotin incorporation levels (like RyR1, a tetramer
subunits channel of approx. 565 kDa with at least 50 Cystein
groups each), pull down assays and subsequent electrophoresis
may not always result in sharp protein bands thus showing
some limitations of the modiﬁed BST method used in the
present work.
The amount and duration of S-nitrosylation of muscle-speciﬁc
proteins are thought to exert either inhibitory (negative) or
activating (positive) effects following nitrosative stress conditions
in various models [2]. While moderate SNO-patterns may be
required for normal activation of e.g. SERCA muscle protein [19],
elevated SNO-patterns may account for inhibitory effects [2], thus
suggesting that SNO regulatory functions in physiological and/or
patho-physiological conditions are even more complex.
The present ﬁndings are based partly on indirect biochemical
SNO-protein detection of total muscle proteins based on BST [7],
combined with immunoblot mapping of key proteins related to
the control of calcium homeostasis. SNO-Cys immunohistochem-
istry at subcellular myoﬁber compartments typically revealed
muscle-speciﬁc distribution patterns of putative SNO-proteins that
were attributable to both muscle phenotype (slow vs. fast type) or
possibly the mode of physical exercise (RE vs. RVE) performed as
countermeasure in bed rest. Nevertheless, even if the BST method
has some limitations [34], we were able to perform a functional
SNO-protein screening showing variable nitrosative stress man-
agement in disused vs. trained human skeletal muscle. The SNO-
protein analysis performed here by indirect detection via BST
neither discriminates between hypo- or hyper-S-nitrosylation of
individually target proteins nor identiﬁes exactly the speciﬁc SNO-
sites in a given target protein [35].
The BBR2-2 Study protocol included two different counter-
measure protocols, resistive exercise (RE) and resistive exercise
combined with whole-body vibration exercise (RVE). This allowed
for direct comparison of nitrosative stress management between
the two modes of countermeasure exercise. Moreover, the present
countermeasure protocols likely affected the activity of Nrf-2
master gene which in turn may regulate the transcriptional
activity of anti-oxidant response elements (AREs) of many cyto-
protective genes [36]. Even if the outcome of both exercise regi-
mens in bed rest was not fully complementary, we propose that
both RVE and RE should generally be considered as effective
countermeasure protocols to mitigate nitrosative stress conditions
in skeletal muscle following extended strain conditions such as in
bed rest immobilization.
Due to the particular nature of nitroso groups (relative short
half-life and their reactivity in the cell) the question arises whether
or not changes in nitrosation may have occurred earlier in bed rest.
Short and/or a midterm term bed rest studies are required in the
future to study the time course of protein nitrosation in muscle
disuse.
Strenuous endurance exercise was reported to increase [37]
rather than to decrease nitrosative stress. However, the present
ﬁndings indicate that short bouts of high-load resistive exercise
performed at regular intervals (35 min. each/2 week) during
60 days of bed rest mitigated high levels of disuse-induced
nitrosative stress in muscle found in the bed-rest-only group. This
may be explained by the two different muscle activity models i.e.
exercise countermeasure following body unloading in healthy
subjects in bed rest vs. normal and/or endurance muscle activity
performed in healthy sport athletes [37]. Nitrosative stress man-
agement therefore seems to be a critical determinant for both
acute overload in muscle exercise in sports (i.e., leading to fatigue
or soreness) and chronically unloaded skeletal muscle in bed rest
(i.e. disuse strain/atrophy mechanism) that appears to be attenu-
ated by exercise as countermeasure.
NO-signaling plays a pleiotropic role in skeletal muscle biology
[8]. For instance muscular NOS isoforms are activity-dependently
expressed [38–40]. Nevertheless, experimental evidence for
altered SNO-modiﬁcations of NOS proteins themselves are less
well documented [41]. We here proposed NOS1 as a new candi-
date on the list of major functional SNO-proteins in human
skeletal muscle. This unexpected new ﬁnding supports the notion
that, in addition to both calcium sensitivity [8] and co-expression
of speciﬁc regulatory proteins, the muscular NOS enzyme activity
might be self-regulated via endogenously released NO-signals,
thereby controlling the level of intracellular NO formation and
bioactivity in a given skeletal myoﬁber. These observations are in
agreement with the proposed presence of a SNO-NOS1 complex
analyzed in a recombinant protein in vitro model [42–44]. Regula-
tion of NOS activity can be also modiﬁed by phosphorylation
mechanisms [45] and in response to myoplasmic calcium ﬂuctua-
tions [46], while NOS isoforms were identiﬁed only recently
as endogenous NO primary sources [47]. Our present ﬁndings
Fig. 8. BST detection of sarcoplasmic membrane SNO-PMCA1 in human skeletal
muscle SOL and VL from bed rest groups. A. Upper panel, PMCA1 immunoblot BST
streptavidin column eluate of SOL (CTR n¼9; RE n¼7; RVE n¼7); a faint PMCA1
immunoreactive band was present in all groups. A. Lower panel, PMCA1 immuno-
blot of streptavidin column eluate of VL (CTR n¼9; RE n¼7; RVE n¼7); a faint
PMCA1 immunoreactive band was present in all groups. Control¼positive control
with human endothelial cell lysates (BD Biosciences). B. Percent change SNO-
PMCA1 in SOL and VL of all groups. No changes in SNO-PMCA1 were found SOL
(CTR 9.4%, p40.05; RE SOL 7.5%, p40.05, RVE 1.78%, p40.05) while changes were
present in VL (CTR 45.55%, pr0.01; RE 21.35%, pr0.01; RVE 19.07%, pr0.01)
after bed rest (* signiﬁcance).
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therefore support the notion that NOS1 can be auto-S-nitrosylated
by local NO-signals in muscle ﬁbers. This would in turn suggest the
presence of an additional yet poorly deﬁned auto-regulatory
component of muscular NOS1 proteins as an additional regulatory
paradigm in skeletal muscle physiology/pathophysiology in view
of the recently proposed S-nitrosylases and/or denitrosylases as
intracellular regulators [35]. To further conﬁrm such NOS1 auto-
regulation via SNO signaling, however, additional experiments
using pharmacological approaches with NO-donors and/or NO-
blocking agents using relevant in vitro or animal models are
necessary and should complement the data from the present
human study.
Some of the functional muscle proteins investigated in this study,
including their putative SNO-sites and potentially SNO-substrates,
have only recently been listed using theoretical computational
prediction methods [48] or have been otherwise reviewed [35].
Alternative SNO-proteome approaches are clearly needed to
further show if altered SNO-protein levels found in inactive vs.
active skeletal muscle in bed rest are due to decreased or
increased S-nitrosylation of speciﬁc SNO-sites on individual
functional SNO-proteins such as the calcium release and calcium
uptake channels as sketched in the graphical abstract (Online
version). Nevertheless, we present ﬁrst experimental proof for
both the presence and the regulation of deﬁned functional SNO-
proteins related to calcium homeostasis in human skeletal
muscle following variable nitrosative stress conditions via post-
translational SNO-protein modiﬁcations in normal vs. disused/
atrophic skeletal muscle.
Fig. 9. Anti-oxidative master gene Nrf-2 regulation in SOL and VL of bed rest subjects. A. Quantitative PCR analysis with Nrf-2 speciﬁc probe in SOL (left panel) and VL (right
panel). Increase in Nrf-2 transcripts was detected after bed rest only in CTR group in VL (þ39.33%, *P¼0.016). B. Nrf-2 immunopositive myonucleus (green) in SOL after bed
rest. Dystrophin (red) was used to label the subsarcolemmal border; nuclei were counterstained with DAPI (blue). Inset, positive Nrf-2 myonucleus for comparison with Nrf-2
negative nuclei outside the myoﬁber. C. Quantitative analysis of Nrf-2 positive myonuclei in SOL (upper panel) and VL (lower panel). The total number of Nrf-2 positive
myonuclei was slightly reduced in both, SOL (Pre, 10.9370.66%, End, 9.0370.75%) and VL (Pre, 9.8370.71%, End, 8.3370.86%) of CTR group after bed rest. In the RE group
no changes were seen in SOL (Pre, 9.6270.77%, End, 11.2571.19%) and VL (Pre, 8.7770.54%, End, 9.3970.54%). In RVE group a increased numbers of Nrf-2 positive
myonuclei were present in SOL (þ30.55%, *P¼0.012) but absent in VL (þ17%, P¼0.15). D. Nrf-2 immunoblot of VL muscle lysates in all groups. A faint Nrf-2 immunoreactive
band with an apparent MW similar to the positive control (contr.) was detected in all samples. Contr.: Jurkat whole cell lysates (SC-2204, Santa Cruz Biotechnology, CA). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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Conclusions
The present report provides multiple strands of evidence for
altered patterns of SNO-proteins including NOS1 itself as signa-
tures of a unique nitrosative stress management in atrophic vs.
trained skeletal muscle following bed rest immobilisation in slow
or mixed-fast human muscle types. Due to the complexity of the
molecular mechanisms and the functional consequences for indi-
vidual muscle cell signaling pathways further investigation of
SNO-protein dysregulation is mandatory. Determination of func-
tional SNO-protein levels in biopsies of the two exercise bed rest
groups provided a thorough basis for re-assessment of efﬁcient
exercise countermeasure protocols. Both RVE, and to lesser extent
RE, signiﬁcantly reduced disuse-induced aberrant SNO-protein
levels and mitigated anti-oxidative master gene over-expression
following bed rest. Nitrosative stress conditions are therefore
instrumental in the regulation of skeletal muscle atrophy or
maladaptation following whole body immobilisation that can be
offset by exercise as countermeasure in various clinical settings,
in rehabilitation, and during microgravity exposure in human
spaceﬂight.
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